Pierre-Olivier Girodet
Overview
Explore the profile of Pierre-Olivier Girodet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zysman M, Herman F, Grassion L, Taille C, Gonzalez-Bermejo J, Guecamburu M, et al.
BMJ Open Respir Res
. 2024 Dec;
11(1.
PMID: 39694677
Introduction: Biologics provide significant benefits in asthma, reducing exacerbations and symptoms. Some biologics have shown promising results in small subgroups of patients with chronic obstructive pulmonary disease (COPD) and frequent...
2.
Girodet P
Am J Respir Crit Care Med
. 2024 May;
210(3):251-252.
PMID: 38701409
No abstract available.
3.
Eyraud E, Maurat E, Sac-Epee J, Henrot P, Zysman M, Esteves P, et al.
Elife
. 2023 Jul;
12.
PMID: 37494277
Bronchi of chronic obstructive pulmonary disease (COPD) are the site of extensive cell infiltration, allowing persistent contact between resident cells and immune cells. Tissue fibrocytes interaction with CD8 T cells...
4.
Henrot P, Eyraud E, Maurat E, Point S, Cardouat G, Quignard J, et al.
Front Pharmacol
. 2022 Sep;
13:939780.
PMID: 36147316
Fibrocytes are monocyte-derived cells able to differentiate into myofibroblasts-like cells. We have previously shown that they are increased in the bronchi of Chronic Obstructive Pulmonary Disease (COPD) patients and associated...
5.
Rosellini P, Amintas S, Caumont C, Veillon R, Galland-Girodet S, Cuguilliere A, et al.
Eur J Cancer
. 2022 Jun;
172:85-95.
PMID: 35759814
Background: Mutations in STK11/LKB1 gene present a negative impact on tumour immune microenvironment, especially with concomitant activating KRAS mutation. These recent data may explain a decreased response to immunotherapy treatment...
6.
Toublanc A, Guecamburu M, Veillon R, Rosellini P, Girodet P, Zysman M
Thorac Cancer
. 2022 Jun;
13(15):2248-2252.
PMID: 35715960
Introduction: Few strategies exist for treatment of patients with small-cell lung cancer (SCLC) extended-stage after failure of first-line platinum-based chemotherapy. Lurbinectedin is a novel RNA-polymerase-II inhibitor investigated as a second-line...
7.
Esteves P, Allard B, Celle A, Dupin I, Maurat E, Ousova O, et al.
Cell Rep
. 2022 Mar;
38(13):110571.
PMID: 35354045
Rhinovirus (RV) infection of the bronchial epithelium is implicated in the vast majority of severe asthma exacerbations. Interestingly, the susceptibility of bronchial epithelium to RV infection is increased in persons...
8.
Hurabielle C, Taille C, Prevot G, Russier M, Didier A, Girodet P, et al.
ERJ Open Res
. 2022 Feb;
8(1).
PMID: 35211620
https://bit.ly/3mmFbQn.
9.
Celle A, Esteves P, Cardouat G, Beaufils F, Eyraud E, Dupin I, et al.
J Allergy Clin Immunol
. 2022 Feb;
150(1):104-113.
PMID: 35143808
Background: Patients with severe asthma show an increase in both exacerbation frequency and bronchial smooth muscle (BSM) mass. Rhinovirus (RV) infection of the bronchial epithelium (BE) is the main trigger...
10.
Cracowski J, Hulot J, Laporte S, Charveriat M, Roustit M, Deplanque D, et al.
Fundam Clin Pharmacol
. 2021 Dec;
36(3):456-467.
PMID: 34954839
Clinical pharmacology is the study of drugs in humans, from first-in-human studies to randomized controlled trials (RCTs) and benefit-risk ratio assessment in large populations. The objective of this review is...